Stallergenes Greer

Stallergenes Greer is a leading global biopharmaceutical company dedicated to transforming the lives of individuals affected by allergies. Specializing in the diagnosis and treatment of respiratory and food allergies, as well as venom allergies, Stallergenes Greer leverages cutting-edge research, development, and commercialization of innovative allergen immunotherapy products and services.

With a strong global presence, Stallergenes Greer operates in 44 countries, supported by nearly 1,100 employees. The company’s commitment to excellence is reflected in its state-of-the-art manufacturing facilities located in both Europe and the United States. Stallergenes Greer International AG, the parent company, oversees GREER Laboratories, Inc. and Stallergenes S.A.S., ensuring a unified approach to advancing allergy immunotherapy.

The primary address for Stallergenes Greer is Zugerstrasse 76b, Baar, Switzerland 6340, CH. Stallergenes Greer is committed to enabling precision medicine and improving the quality of life for people with allergies worldwide. We invite the manager of Stallergenes Greer to create a customized and exclusive company showcase and product listing on our platform.